Product Details:
Minimum Order Quantity | 20 Box |
Brand | Cresp |
Packaging Type | Box |
Dosage | 40 Mcg |
Manufactured by | Dr Reddy's |
Composition | Darbepoetin Alfa Injection |
Additional Information:
Product Details:
Minimum Order Quantity | 10 Box |
Usage | Clinical |
Packaging Type | Box |
Brand | Mircera |
Dose/Strength | 50 mcg/0.3 ml |
Manufactured by | Roche |
Product Details:
Minimum Order Quantity | 10 Piece |
Packaging Type | Box |
Brand | Mircera |
Dosage | 100 mcg/0.3 ml |
Composition | Methoxy polyethylene glycol-epoetin beta |
Manufactured by | Roche |
Product Details:
Minimum Order Quantity | 20 Box |
Packaging Type | Box |
Dose/Strength | 2000 NE |
Composition | Oldatos injekcio eloretoltott fecskendoben |
Manufactured by | Roche |
Product Details:
Minimum Order Quantity | 10 Vial |
Brand | BOTOX |
Packaging Size | BOX |
BOTOX is indicated for:
Neurologic disorders:
• treatment of focal spasticity, including:
dynamic equinus foot deformity due to spasticity in ambulant paediatric cerebral palsy patients, two years of age or older
wrist and hand disability due to upper limb spasticity associated with stroke in adults
ankle and foot disability due to lower limb spasticity associated with stroke in adults
• symptomatic relief of blepharospasm, hemifacial spasm and idiopathic cervical dystonia (spasmodic torticollis)
• prophylaxis of headaches in adults with chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine)
Bladder disorders:
• management of bladder dysfunctions in adult patients who are not adequately managed with anticholinergics
overactive bladder with symptoms of urinary incontinence, urgency and frequency
neurogenic detrusor overactivity with urinary incontinence due to subcervical spinal cord injury (traumatic or non-traumatic), or multiple sclerosis
Skin and skin appendage disorders:
• management of severe hyperhidrosis of the axillae, which does not respond to topical treatment with antiperspirants or antihidrotics
• temporary improvement in the appearance of:
moderate to severe vertical lines between the eyebrows seen at maximum frown (glabellar lines) and/or,
moderate to severe lateral canthal lines (crow's feet lines) seen at maximum smile and/or,
moderate to severe forehead lines seen at maximum eyebrow elevation
when the severity of the facial lines has an important psychological impact in adult patients.
Additional Information: